Jill Howlin’s drawings about science and policy have a unique, edgy style that packs a punch. I have invited her to weigh in here now and then with new illustrations that touch upon stem cell or other innovative biomedical matters. Jill’s new drawing today relates to some key stem cell issues such as clinical safety, choice of stem cells, homologous […]
Stem cells run amok: Jill Howlin’s satirical cartoon look Read More »
Superstar soccer/football player Cristiano Ronaldo will reportedly undergo a stem cell treatment procedure to try to mend a hamstring injury. He is one in a long line of sports stars who are taking this gamble. This is reported by the highly rigorous source, The Daily Mail as well as the Independent. The latter quoted his mother
Stem cells for goals? Star Ronaldo to get treatment Read More »
What is direct reprogramming ? There’s some big, positive news on this stem cell front today. All chemical direct reprogramming Two new innovative papers both by teams led by Sheng Ding of Gladstone Institutes with UCSF report all-chemical direct reprogramming of human somatic cells. Ding’s team took skin cells and by exposing them to cocktails of
Big stem cell news: dynamic duo of all-chemical direct reprogramming reports Read More »
What is a Vatican Stem Cell Meeting like? Over the years, the Vatican has expressed interest and even invested money in the adult stem cell field. Not surprisingly, they’ve also been critical of embryonic stem cell research. Interestingly their own stem cell meetings have at times stimulated heated debate for various reasons and one was even cancelled with
Perspectives on Vatican Stem Cell Meeting: CIRM, Embryonic & Adult Stem Cells Read More »
Have you had a stem cell treatment and if so, what was your experience like? Please also see our 2020 guide and polls on stem cell treatment cost. I really value the diversity of readers on this blog from all over the world. I know we have a lot of readers who are patients and have had
If you’ve had a stem cell treatment, how was your experience? Read More »
A new study on treating pain with a unique stem cell connection caught my attention. The paper was from a team at Pfizer led by Edward B. Stevens. Talk about bench to bedside, these researchers went all the way from patients to patient somatic cells to reprogrammed IPSC to neurons to model pain in a dish
Pain in a dish? Drug testing bench to bedside with IPS cells Read More »
Blood testing biotech Theranos finds itself in a hole that seemingly just keeps getting deeper with the report today that the company is under criminal investigation. Can it bounce back? Some people are really upset with Theranos for allegedly making misleading statements including both to investors and the government about its technologies. It’s no exaggeration
Will there be a Theranos of the stem cell field? Read More »
A new paper from Shoukhrat Mitalipov’s lab on stem cell mitochondria points to a pattern whereby induced pluripotent stem (IPS) cells tend to have more problems if they are from older patients. New Mitalipov paper What does this paper mean for the stem cell field and could it impact more specifically the clinical applications of IPS
New Mitalipov paper on stem cell mitochondria: challenge for IPS cell field? Read More »
Four or five years ago the top stem cell story was the battle over federal funding of human embryonic stem (ES) cell research in the U.S. by James Sherley and Theresa Deisher. They were the two opponents of ES cell research making the most national headlines. Nature did a whole piece back then on Deisher
Where are ES cell foes James Sherley & Theresa Deisher now? Read More »
There’s been an interesting and diverse discussion going on here on this blog lately related to some stem cell translational things including a stem cell clinic operating in Sacramento (see 50+ comments on that post) and then more recently on a new paper from the Centeno clinic. .@pknoepfler Did most (or all) participants in this study pay
Do for-profit stem cell studies have inherent potential biases? Read More »